Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis

J Clin Rheumatol. 2016 Aug;22(5):282-4. doi: 10.1097/RHU.0000000000000408.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antirheumatic Agents / administration & dosage
  • Arthritis, Juvenile* / diagnosis
  • Arthritis, Juvenile* / drug therapy
  • Arthritis, Juvenile* / immunology
  • Drug Monitoring / methods
  • Drug Resistance, Multiple
  • Female
  • Humans
  • Interleukin-12 / antagonists & inhibitors
  • Interleukin-23 / antagonists & inhibitors
  • Male
  • Patient Acuity
  • Symptom Assessment / methods
  • Treatment Outcome
  • Ustekinumab / administration & dosage*

Substances

  • Antirheumatic Agents
  • Interleukin-23
  • Interleukin-12
  • Ustekinumab